Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Spain
Summary - Omalizuma Suminist (Doe), Nilotinis (Doe), Altrombopag (Doe), Dabrafenib (Doe), Secukinumab (Doe), Pasopanine (Doe), Trametinib (Doe), Everolimus (Doe) And Midostaurine (Doe)
Deadline - Aug 20, 2025
GT reference number - 114959570
Product classification - Pharmaceutical products
Address - Spain
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 114959570
Document Type - Tender Notices
Description - notice_title: Omalizuma Suminist (Doe), Nilotinis (Doe), Altrombopag (Doe), Dabrafenib (Doe), Secukinumab (Doe), Pasopanine (Doe), Trametinib (Doe), Everolimus (Doe) And Midostaurine (Doe)local title:: Suministro de Omalizumab (DOE), Nilotinib (DOE), Eltrombopag (DOE), Dabrafenib (DOE), Secukinumab (DOE), Pazopanib (DOE), Trametinib (DOE), Everolimus (DOE) y Midostaurina (DOE)Contract Duration: : 1 AñosContract Type: : SupplyGross Budget Euro: : 19969728.32Net Budget Euro: : 19201661.85Gross Budget LC: : 19969728.32Net Budget LC: : 19201661.85Tender URL: : https://www.contratacion.euskadi.eus/KPELicitacion est_amount: 19969728.32 lot_details: 1: L1_OMALIZUMAB (DOE), 2: L2_NILOTINIB (DOE), 3
Gt Ref Id - 114959570
Deadline - Aug 20, 2025
Similar Tenders :
Summary:
|
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database